Efficacité et sécurité comparatives du bimekizumab dans la spondyloarthrite axiale : Une revue systématique de la littérature et une méta-analyse en réseau
Rheumatology (Oxford). 2023 doi: 10.1093/rheumatology/kead598 Epub ahead of print
This systematic literature review and network meta-analysis provides evidence for bimekizumab being an efficacious option in the management of both b/tsDMARD-naïve and experienced patients across the axSpA spectrum, with similar safety and tolerability to existing treatments.